SCHEMBL4586013

SCHEMBL4586013

CC(P)O[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9292 0.72
SCHEMBL634286 0.69
SCHEMBL2542572 0.67
SCHEMBL227419 0.67
SCHEMBL3760197 0.67
SCHEMBL98755 0.67
SCHEMBL1426682 0.67
SCHEMBL514568 0.67
SCHEMBL249451 0.67
SCHEMBL271044 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534823-A4 THE USE OF ISOCYANATE LINKERS TO MAKE HYDROLYZABLE ACTIVE AGENT BIOPOLYMER CONJUGATES BIOMARIN PHARM INC (US) 2008-12-31 EP disclosed
US-20060029586-A1 Use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates BIOMARIN PHARMACEUTICAL INC. 2006-02-09 US disclosed
WO-2005007663-A9 FLUOROGENIC ENZYME SUBSTRATES AND USES THEREOF IRM LLC (US) 2005-09-15 WO disclosed
US-20050153306-A1 Fluorogenic enzyme substrates and uses thereof IRM LLC (BM) 2005-07-14 US disclosed
EP-1534823-A2 THE USE OF ISOCYANATE LINKERS TO MAKE HYDROLYZABLE ACTIVE AGENT BIOPOLYMER CONJUGATES BioMarin Pharmaceutical Inc. (US) 2005-06-01 EP disclosed
WO-2005007663-A2 FLUOROGENIC ENZYME SUBSTRATES AND USES THEREOF IRM LLC (BM) 2005-01-27 WO disclosed
US-20040176270-A1 Use of isocyanate linkers to make hydrolyzable active agent biopolymer conjugates BIOMARIN PHARMACEUTICAL INC. 2004-09-09 US disclosed
WO-2004008101-A2 THE USE OF ISOCYANATE LINKERS TO MAKE HYDROLYZABLE ACTIVE AGENT BIOPOLYMER CONJUGATES BIOMARIN PHARMACEUTICAL INC. (US) 2004-01-22 WO disclosed
EP-0776330-B1 PHOTOLABILE COMPOUNDS AND METHODS FOR THEIR USE AFFYMAX TECH NV (AN) 2003-08-20 EP disclosed
WO-2002099078-A2 FUNCTIONAL PROTEOMIC PROFILING IRM LLC (BM) 2002-12-12 WO disclosed
US-5917016-A USEFUL AS PHOTOCLEAVABLE LINKING GROUPS IN SOLID PHASE SYNTHESIS AFFYMAX TECHNOLOGIES N.V. (GB) 1999-06-29 US disclosed
US-5874589-A Methods for synthesizing diverse collections of tetramic acids and derivatives thereof GLAXO WELLCOME, INC. (US) 1999-02-23 US disclosed
US-5846839-A Methods for hard-tagging an encoded synthetic library GLAXO GROUP LIMITED (GB) 1998-12-08 US disclosed
US-5739386-A PHOTOCLEAVABLE LINKING GROUPS IN SOLID PHASE SYNTHESIS AFFYMAX TECHNOLOGIES N.V. (GB) 1998-04-14 US disclosed
WO-1997041093-A1 METHODS FOR THE SYNTHESIS OF FMOC PROTECTED AMINES AFFYMAX TECHNOLOGIES N.V. (GB) 1997-11-06 WO disclosed
EP-0776330-A2 PHOTOLABILE COMPOUNDS AND METHODS FOR THEIR USE AFFYMAX TECHNOLOGIES N.V. (AN) 1997-06-04 EP disclosed
US-5549974-A IMMOBILIZATION AFFYMAX TECHNOLOGIES NV (AN) 1996-08-27 US disclosed
WO-1996000148-A1 METHODS FOR THE SOLID PHASE SYNTHESIS OF THIAZOLIDINONES, METATHIAZANONES, AND DERIVATIVES THEREOF AFFYMAX TECHNOLOGIES N.V. (AN) 1996-01-04 WO disclosed
WO-1996000378-A1 PHOTOLABILE COMPOUNDS AND METHODS FOR THEIR USE AFFYMAX TECHNOLOGIES N.V. (AN) 1996-01-04 WO disclosed
WO-1995018971-A1 METHODS FOR THE SOLID PHASE SYNTHESIS OF GLYCOCONJUGATES AFFYMAX TECHNOLOGIES N.V. (NL) 1995-07-13 WO disclosed